Neurocrine Biosciences, Prothena, Rent-A-Center Upgraded

Neurocrine Biosciences, Prothena, and Rent-A-Center stocks are on analysts' bullish radar today

Apr 12, 2017 at 9:30 AM
facebook twitter linkedin

Analysts are weighing in on drugmakers Neurocrine Biosciences, Inc. (NASDAQ:NBIX) and Prothena Corporation PLC (NASDAQ:PRTA), as well as retail stock Rent-A-Center. Here's a quick roundup of today's bullish brokerage notes on shares of NBIX and PRTA, as well as RCII stock.

Neurocrine Biosciences Signals FDA-Induced Bull Gap

NBIX stock is set to gap 22.2% higher at the open, after the Food and Drug Administration (FDA) approved the company's movement disorder drug, Ingrezza. Further bolstering the shares are price-target hikes at Leerink and Jefferies to $68 and $65, respectively -- both in record-high territory. This is more of the same from the brokerage crowd, as all 11 analysts covering Neurocrine Biosciences, Inc. rate it a "buy" or "strong buy." Yesterday, the stock settled at $41.48, up 7.2% year-to-date.

Prothena Secures Bullish Initiation

PRTA stock is pointed 1.3% higher ahead of the opening bell, lifted by an "overweight" initiation at Piper Jaffray -- which also set a price target of $69, in annual-high territory. Separately, Prothena Corporation PLC entered into a purchasing agreement with Boehringer Ingelheim. Taking a step back, it's been a rough month for PRTA shares, down 10.6% since the start of April. While shareholders can't be happy with the losses, plenty of short sellers are. Over 19% of the stock's float is sold short, which translates into 15 days' worth of trading, at PRTA's typical volumes.

Upgrade Could Extend RCII Stock's Recent Surge

RCII's week-to-date rally -- powered by Marcato Capital's call for a company sale -- looks like it will continue today. The stock is up 3.1% in electronic trading, after ending Tuesday at $10.48 -- having advanced 9.2% since last Friday's close. Stoking Rent-A-Center stock's bullish flames is an upgrade to "strong buy" from "market perform" at Raymond James. The shares' recent strength could be turning up the heat on short sellers. Nearly 20 million RCII shares are sold short, which would take two weeks to cover, based on the stock's average daily trading volume.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners